
Research Assistant
- About
-
Biography
Charlotte joined the Health Economics Research Unit (HERU) in November 2019 as a Research Assistant under the Assessment of Health Technologies theme. Currently, she is involved in the critical assessment of the economic methods used in single technology assessments as part of the evidence review group within the university. Previous projects include the conceptualisation and development of an economic model for childhood Asthma, health economic analysis alongside the RAACENO clinical trial and conducting a micro-costing analysis for the EDNA study. She graduated from the University of York in January 2020 with a distinction in MSc Health Economics; her MSc thesis investigated time preference as a mediator of the spousal correlation in smoking. This was completed within the unit during the summer of 2019. She also graduated from the University of Birmingham in June 2018 with a BSc Hons in Mathematical Economics and Statistics.
Qualifications
- BSc Mathematical Economics and Statistics2018 - University of Birmingham
- MSc Health Economics2020 - University of York
- Research
-
Research Areas
Economics
- Publications
-
Page 1 of 1 Results 1 to 10 of 10
Early detection of neovascular age-related macular degeneration: an economic evaluation based on data from the EDNA study
British Journal of Ophthalmology, vol. 106, no. 12, pp. 1754-1761Contributions to Journals: ArticlesReducing asthma attacks in children using exhaled nitric oxide (RAACENO) as a biomarker to inform treatment strategy: a multicentre, parallel, randomised, controlled, phase 3 trial
The Lancet. Respiratory medicine, vol. 10, no. 6, pp. 584-592Contributions to Journals: ArticlesTreatment guided by fractional exhaled nitric oxide in addition to standard care in 6- to 15-year-olds with asthma: the RAACENO RCT
Efficacy and Mechanism Evaluation, vol. 9, no. 4, pp. 1-153Contributions to Journals: ArticlesNon-invasive testing for early detection of neovascular macular degeneration in unaffected second eyes of older adults: EDNA diagnostic accuracy study
Health Technology Assessment, vol. 26, no. 8Contributions to Journals: ArticlesAxicabtagene ciloleucel for treating relapsed or refractory low-grade non-Hodgkin lymphoma
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsA multicentre open label randomised clinical trial using exhaled nitric oxide in addition to standard care to reduce asthma attacks in children
Efficacy and Mechanism EvaluationContributions to Journals: ArticlesSecukinumab for treating plaque psoriasis in children and young people
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsTeduglutide for treating short bowel syndrome
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsVenetoclax with a hypomethylating agent or low dose cytarabine for untreated acute myeloid leukaemia unsuitable for intensive chemotherapy
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned ReportsDarolutamide with androgen deprivation therapy for treating non-metastatic hormone-relapsed prostate cancer
Evidence Review Group report in support of NICE STA Programme. London: National Institute for Health and Care ExcellenceBooks and Reports: Commissioned Reports